QSAR and the prediction of T-cell epitopes

Current Proteomics

Volumn 5, Issue 2, 2008, Pages 73-95

  Doytchinova, Irini A ^a   Flower, Darren R ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Additive method; MHC class I; MHC class II; Proteasome; TAP

Indexed keywords

EID: 47249133852     PISSN: 15701646     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016408784911945     Document Type: Review

References (178)

1. Altfeld, M. A., Livingston, B., Reshamwala, N., Nguyen, P. T., Addo, M. M., Shea, A., Newman, M., Fikes, J., et al. (2001). Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif. J. Virol. 75: 1301-11.
2. Altuvia, Y., Schueler, O. and Margalit, H. (1995). Ranking potential binding peptides to MHC molecules by a computational threading approach. J. Mol. Biol. 249: 244-50.
3. Altuvia, Y. and Margalit, H. (2000). Sequence signals for generation of antigenic peptides by the proteasome: Implications for proteasomal cleavage mechanism. J. Mol. Biol. 295: 879-90.
4. Andrews, P. R., Craik, D. J. and Martin, J. L. (1984). Functional group contributions to drug-receptor interactions. J. Med. Chem. 27: 1648-57.
5. Babine, R. E. and Bender, S. L. (1997). Molecular recognition of protein-ligand complexes: applications to drug design. Chem. Rev. 97, 1354-472.
6. Baker, K., Bleczinski, C., Lin, H., Salazar-Jimenez, G., Sengupta, D., Krane, S. and Cornish, V.W. (2002). Chemical complementation: a reaction-independent genetic assay for enzyme catalysis. Proc. Natl. Acad. Sci. USA 99: 16537-42.
7. Beninga, J., Rock, K. L. and Goldberg, A. L. (1998). Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. J. Biol. Chem. 273: 18734-42.
8. Bhasin, M. and Raghava, G. P. (2004a). Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine 22: 3195-204.
9. Bhasin, M. and Raghava, G. P. (2004b). Analysis and prediction of affinity of TAP binding peptides using cascade SVM. Protein Sci. 13: 596-607.
10. Bhasin, M. and Raghava, G. P. (2004c). SVM based method for predicting HLA-DRB1*0401 binding peptides in an antigen sequence. Bioinformatics 20: 421-3.
11. Bindal, M. C., Singh, P. and Gupta, S. P. (1982). Structure - activity studies on hallucinogenic phenylalkylamines using Fujita-Ban approach. Arzneimittelforschung 32: 719-21.
12. Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L. and Wiley, D. C. (1987). Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329: 506-12.
13. Bleicher, K. H., Bohm, H. J., Muller, K. and Alanine, A. I. (2003). Hit and lead generation: beyond high-throughput screening. Nat. Rev. Drug Discov. 2: 369-78.
14. Blythe, M. J., Doytchinova, I. A. and Flower, D. R. (2002). JenPep: a database of quantitative functional peptide data for immunology. Bioinformatics 18: 434-9.
15. Böhm, H. J. and Klebe, G. (1996). What can we learn from molecular recognition in protein-ligand complexes for the design of new drugs? Angew. Chem. Int. Ed. Engl. 35: 2588-614.
16. Bordner, A. J. and Abagyan, R. (2006). Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes. Proteins 63: 512-26.
17. Bradley, A. P. (1997). The use of the area under the ROC curve in the evaluation of machine learning algorithms. Pattern Recognition 30: 1145-59.
18. Brusic, V., Rudy, G., Honeyman, G., Hammer, J. and Harrison, L. (1998). Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics 14: 121-30.
19. Bui, H. H., Schiewe, A. J., von Grafenstein, H. and Haworth, I. S. (2006). Structural prediction of peptides binding to MHC class I molecules. Proteins 63: 43-52.
20. Burden, F. R. and Winkler, D. A. (2005). Predictive Bayesian neural network models of MHC class II peptide binding. J. Mol. Graph. Model. 23: 481-9.
21. Calderone, C. T. and Williams, D. H. (2001). An enthalpic component in cooperativity: the relationship between enthalpy, entropy, and noncovalent structure in weak associations. J. Am. Chem. Soc. 123: 6262-7.
22. Cammarata, A. and Yau, S. (1970). Predictability of correlations between in vitro tetracycline potencies and substituent indices. J. Med. Chem. 13: 93-7.
23. Carson, R. T., Vignali, K. M., Woodland, D. L. and Vignali, D. A. (1997). T-cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity 7: 387-99.
24. Cascio, P., Hilton, C., Kisselev, A. F., Rock, K. L. and Goldberg, A. L. (2001). 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J. 20: 2357-66.
25. Celis, J. E., Wolf, H. and Ostergaard, M. (2000). Bladder squamous cell carcinoma biomarkers derived from proteomics. Electrophoresis 21: 2115-21.
26. Chen, L. and Jondal, M. (2004). Alternative processing for MHC class I presentation by immature and CpG-activated dendritic cells. Eur. J. Immunol. 34: 952-60.
27. Chicz, R. M., Urban, R. G., Lane, W. S., Gorga, J. C., Stern, L. J., Vignali, D. A. A. and Strominger, J. L. (1992). Predominant naturally processed peptides bound to HLA DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358: 764-8.
28. Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A. A., Lane, W. S. and Strominger, J. L. (1993). Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178: 27-47.
29. Coyle, A. J. and Gutierrez-Ramos, J. C. (2001). The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nature 363: 203-9.
30. Craiu, A., Akopian, T., Goldberg, A. and Rock, K. L. (1997). Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc. Natl. Acad. Sci. USA 94: 10850-5.
31. Cui, J., Han, L. Y., Lin, H. H., Zhang, H. L., Tang, Z. Q., Zheng, C. J., Cao, Z. W. and Chen, Y. Z. (2007). Prediction of MHC-binding peptides of flexible lengths from sequence-derived structural and physicochemical properties. Mol. Immunol. 44: 866-77.
32. Dalpiaz, A., Gessi, S., Varani, K. and Borea, P. A. (1997). De novo analysis of receptor binding affinity data of 8-ethenyl-xantine antagonists to adenosine A1 and A2A receptors. Arzneimittelforschung 47: 591-4.
33. Daniel, S., Brusic, V., Caillat-Zucman, S., Petrovsky, N., Harrison, L., Riganelli, D., Sinigaglia, F., Gallazzi, F., et al. (1998). Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J. Immunol. 161: 617-24.
34. Davies, M. N., Sansom, C. E., Beazley, C. and Moss, D. S. (2003). A novel predictive technique for the MHC class II peptide-binding interaction. Mol. Med. 9: 220-5.
35. Davies, M. N., Hattotuwagama, C. K., Moss, D. S., Drew, M. G. and Flower, D. R. (2006). Statistical deconvolution of enthalpic energetic contributions to MHC-peptide binding affinity. BMC Struct. Biol. 6: 5.
36. de la Salle, H., Houssaint, E., Peyrat, M. A., Arnold, D., Salamero, J., Pinczon, D., Stevanovic, S., Bausinger, H., et al. (1997). Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens. J. Immunol. 158: 4555-63.
37. Dessen, A., Lawrence, C. M., Cupo, S., Zaller, D. M. and Wiley, D.C. (1997). X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 7: 473-81.
38. Ding, S. J., Li, Y., Tan, Y. X., Jiang, M. R., Tian, B., Liu, Y. K., Shao, X. X., Ye, S. L., et al. (2004). From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol. Cell Proteomics 3: 73-81.
39. Djaballah, H., Harness, J. A., Savory, P. J. and Rivett, A. J. (1992). Use of serine-protease inhibitors as probes for the different proteolytic activities of the rat liver multicatalitic proteinase complex. Eur. J. Biochem. 209: 629-34.
40. Dönnes, P. and Elofsson, A. (2002). Prediction of MHC class I binding peptides, using SVMHC. BMC Bioinformatics 3: 25.
41. Dönnes, P. and Kohlbacher, O. (2005). Integrated modeling of the major events in the MHC class I antigen processing pathway. Protein Sci. 14: 2132-40.
42. Doytchinova, I. A., Blythe, M. J. and Flower, D. R. (2002). Additive method for the prediction of protein-peptide binding affinity. Application to the MHC class I molecule HLA-A*0201. J. Proteome Res. 1: 263-72.
43. Doytchinova, I. A. and Flower, D. R. (2003a): Towards the in silico identification of class II restricted T-cell epitopes: a partial least squares iterative self-consistent algorithm for affinity prediction. Bioinformatics 19: 2263-70.
44. Doytchinova, I. and Flower, D. (2003b). The HLA-A2-supermotif: a QSAR definition. Org. Biomol. Chem. 1: 2648-54.
45. Doytchinova, I., Hemsley, S. and Flower, D. R. (2004a). Transporter associated with antigen processing preselection of peptides binding to the MHC: a bioinformatic evaluation. J. Immunol. 173: 6813-9.
46. Doytchinova, I. A., Walshe, V., Jones, N., Gloster, S., Borrow, P. and Flower, D. R. (2004b). Coupling in silico and in vitro analysis of peptide-MHC binding: A bioinformatics approach enabling prediction of superbinding peptides and anchorless epitopes. J. Immunol. 172: 7495-502.
47. Doytchinova, I. A., Guan, P. and Flower, D. R. (2006). EpiJen: a server for multistep T-cell epitope prediction. BMC Bioinformatics 7: 131.
48. Doytchinova, I. A. and Flower, D. R. (2006). Class I T cell epitope prediction: improvements using a combination of Proteasome cleavage, TAP affinity, and MHC binding. Mol. Immunol. 43: 2037-44.
49. Drummelsmith, J., Brochu, V., Girard, I., Messier, N. and Ouellette, M. (2003). Proteome mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms. Mol. Cell Proteomics 2: 146-55.
50. Ellis, J. M., Henson, V., Slack, R., Ng, J., Hartzman, R. J. and Hurley, C. K. (2000). The frequencies of HLA-A2 alleles in five U.S. population groups: Predominance of A*02011 and identification of HLA-A*0231. Human Immunology 61: 334-40.
51. Fagerberg, T., Cerottini, J. C. and Michielin, O. (2006). Structural prediction of peptides bound to MHC class I. J. Mol. Biol. 356: 521-46.
52. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G. and Rammensee, H. G. (1991). Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351: 290-6.
53. Falk, K. and Rotzschke, O. (1993). Consensus motifs and peptide ligands of MHC class I molecules. Semin. Immunol. 5: 81-94.
54. Flower, D. R., McSparron, H., Blythe, M. J., Zygouri, C., Taylor, D., Guan, P., Wan, S., Coveney, P. V., et al. (2003). Computational vaccinology: quantitative approaches. Novartis Found Symp. 254: 102-20.
55. Flower, D. R. (2003). Towards in silico prediction of immunogenic epitopes. Trends Immunol. 24: 667-74.
56. Franco, A., Southwood, S., Arrhenius, T., Kuchroo, V. K., Grey, H. M., Sette, A. and Ishioka, G. Y. (1994). T-cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis. Eur. J. Immunol. 24: 940-6.
57. Free, S. M. Jr. and Wilson, J. W. (1964). A mathematical contribution to structure - activity studies. J. Med. Chem. 7: 395-9.
58. Fujita, T. and Ban, T. (1971). Structure - activity study of phenethylamines as substrates of biosynthetic enzymes of sympathetic transmitters. J. Med. Chem. 14: 148-52.
59. Garboczi, D. N., Ghosh, P., Utz, U., Fan, Q. R., Biddison, W. E. and Wiley, D. C. (1996). Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384: 134-41.
60. Garrett, T. P., Saper, M. A., Bjorkman, P. J., Strominger, J. L. and Wiley, D. C. (1989). Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342: 692-6.
61. Geier, E., Pfeifer, G., Wilm, M., Lucchiari-Hartz, M., Baumeister, W., Eichmann, K. and Niedermann, G. (1999). A giant protease with potential to substitute for some functions of the proteasome. Science 283: 978-81.
62. Germain, R. N. (1994). MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76: 287-99.
63. Godkin, A. J., Smith, K. J., Willis, A., Tejada-Simon, M. V., Zhang, J., Elliott, T. and Hill, A. V. (2001). Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions. J. Immunol. 166: 6720-7.
64. Golgberg, A. L., Cascio, P., Saric, T. and Rock, K. L. (2002). The importance of the proteasome and subsequent proteolitic steps in the generation of antigenic peptides. Mol. Immunol. 39: 147-64.
65. Gombar, V. (1986). Quantitative Structure - Activity Relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3- ([(substitutedamido)alkyl] amino)-2-propanols. Arzneimittelforschung 36: 1014-8.
66. Greenbaum, D. C., Baruch, A., Grainger, M., Bozdech, Z., Medzihradszky, K. F., Engel, J., DeRisi, J., Holder, A. A., et al. (2002). A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science 298: 2002-6.
67. Guan, P., Doytchinova, I. A. and Flower, D.R. (2003a). HLA-A3 supermotif defined by quantitative structure-activity relationship analysis. Protein Eng. 16: 11-8.
68. Guan, P., Doytchinova, I. A., Zygouri, C. and Flower, D. R. (2003b). MHCPred: bringing a quantitative dimension to the online prediction of MHC binding. Appl. Bioinformatics 2: 63-6.
69. Guan, P., Doytchinova, I., Hattotuwagama, C. and Flower, D. R. (2006). MHCPred 2.0, an updated quantitative T cell epitope prediction server. Appl. Bioinformatics 5: 55-61.
70. Gubler, B., Daniel, S., Armandola, E. A., Hammer, J., Caillat-Zucman, S. and van Endert, P. M. (1998). Substrate selection by transporters associated with antigen processing occurs during peptide binding to TAP. Mol. Immunol. 35: 427-33.
71. Guéguen, M., Biddison, W. and Long, E. O. (1994). T cell recognition of an HLA-A2-restricted epitope derived from a cleaved signal sequence. J. Exp. Med. 180: 1989-94.
72. Guo, H. C., Madden, D. R., Silver, M. L., Jardetzky, T. S., Gorga, J. C., Strominger, J. L. and Wiley, D. C. (1993). Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705. Proc. Natl. Acad. Sci. USA 90: 8053-7.
73. Hajduk, P. J., Sheppard, G., Nettesheim, D. G., Olejniczak, E. T., Shuker, S. B., Meadows, R. P., Steinman, D. H., Carrera, G. M., et al. (1997). Discovery of potent nonpeptide inhibitors of Stromelysin using SAR by NMR. J. Am. Chem. Soc. 119: 5818-27.
74. Hammett, L. P. (1937). The effect of structure upon the reactions of organic compounds. Benzene derivatives. J. Am. Chem. Soc.59: 96-106.
75. Hanada K, Yewdell J. W. and Yang J.C. (2004). Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 427: 252-6.
76. Hansch, C., Maloney, P. P., Fujita, T. and Muir, R. M. (1962). Correlation of biological activity of phenoxyacetic acids with Hammett substituent constants and partition coefficients. Nature 194: 178-80.
77. Henderson, R. A., Michel, H., Sakaguchi, K., Shabanowitz, J., Appella, E., Hunt, D. F. and Engelhard, V.H. (1992). HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255: 1264-6.
78. Hennecke, J. and Wiley, D.C. (2002). Structure of a complex of the human a/b T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): Insight into TCR cross-restriction and alloreactivity. J. Exp. Med. 195: 571-81.
79. Hunt, D. F., Michel, H., Dickinson, T. A., Shabanowitz, J., Cox, A. L., Sakaguchi, K. and Appella, E. (1992a). Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 256: 1817-20.
80. Imanishi, S. and Harada, K. (2004). Proteomics approach on microcystin binding proteins in mouse liver for investigation of microcystin toxicity. Toxicon. 43: 651-9.
81. Janeway, C. A. (2001). Immunobiology: the immune system in health and disease. Churchill Livingstone.
82. Jojic, N., Reyes-Gomez, M., Heckerman, D., Kadie, C. and Schueler-Furman, O. (2006). Learning MHC I--peptide binding. Bioinformatics 22: e227-35.
83. Jones, E. Y. (1997). MHC class I and class II structures. Curr. Opin. Immunol. 9: 75-9.
84. Kageyama, S., Isono, T., Iwaki, H., Wakabayashi, Y., Okada, Y., Kontani, K., Yoshimura, K., Terai, A., et al. (2004). Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clin. Chem. 50: 857-66.
85. Karpenko, O., Shi, J. and Dai, Y. (2005). Prediction of MHC class II binders using the ant colony search strategy. Artif. Intell. Med. 35: 147-56.
86. Kawashima, I., Tsai, V., Southwood, S., Takesako, K., Sette, A. and Celis, E. (1999). Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells. Cancer Res. 59: 431-5.
87. Keightley, J. A., Shang, L. and Kinter, M. (2004). Proteomic analysis of oxidative stress-resistant cells: a specific role for aldose reductase overexpression in cytoprotection. Mol. Cell Proteomics 3: 167-75.
88. Khanna, R., Burrows, S. R., Moss, D. J. and Silins, S. L. (1996). Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies. J. Virol. 70: 5357-62.
89. Krensky, A. M. and Clayberger, C. (1996). Structure of HLA molecules and immunosuppressive effects of HLA derived peptides. Int. Rev. Immunol. 13: 173-85.
90. Kridel, S. J., Axelrod, F., Rozenkrantz, N. and Smith, J. W. (2004). Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res. 64: 2070-5.
91. Kuttler, C., Nussbaum, A. K., Dick, T. P., Rammensee, H.-G., Schild, H. and Hadeler, K.-P. (2000). An algorithm for the prediction of proteasome cleavages. J. Mol. Biol. 298: 417-29.
92. Lankat-Buttgereit, B. and Tampé, R. (1999). The transporter associated with antigen processing TAP: structure and function. FEBS Lett. 464: 108-12.
93. Larsen, M. V., Lundegaard, C., Lamberth, K., Buus, S., Brunak, S., Lund, O. and Nielsen, M. (2005). An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur. J. Immunol. 35: 2295-303.
94. Lautscham, G., Rickinson, A. and Blake, N. (2003). TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus. Microbes Infect. 5: 291-9.
95. Liu, W., Meng, X., Xu, Q., Flower, D. R. and Li, T. (2006). Quantitative prediction of mouse class I MHC peptide binding affinity using support vector machine regression (SVR) models. BMC Bioinformatics 7: 182.
96. Lopes, A. R., Jaye, A., Dorrell, L., Sabally, S., Alabi, A., Jones, N. A., Flower, D. R., De Groot, A., et al. (2003). Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection. J. Immunol. 171: 307-16.
97. Luckey, C. J., King, G. M., Marto, J. A., Venketeswaran, S., Maier, B. F., Crotzer, V. L., Colella, T. A., Shabanowitz, J., et al. (1998). Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteosomal epitope generation in the cytosol. J. Immunol. 161: 112-21.
98. Luckey, C. J., Marto, J. A., Partridge, M., Hall, E., White, F. M., Lippolis, J. D., Shabanowitz, J., Hunt, D. F., et al. (2001). Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors. J. Immunol. 167: 1212-21.
99. Madden, D. R., Gorga, J. C., Strominger, J. L. and Wiley, D. C. (1992). The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70: 1035-48.
100. Madden, D. R., Garboczi, D. N. and Wiley, D. C. (1993). The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75: 693-708.
101. Madden, D. R. (1995). The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13: 587-622.
102. Mallios, R. R. (2001). Predicting class II MHC/peptide multi-level binding with an iterative stepwise discriminant analysis meta-algorithm. Bioinformatics 17: 942-8.
103. Maly, D. C., Choong, I. C. and Ellman, J. A. (2000). Combinatorial target-guided ligand assembly: Identification of potent subtype-selective c-Src inhibitors. Proc. Natl. Acad. Sci. USA 97: 9367-72.
104. Matsumura, M., Fremont, D. H., Peterson, P. A. and Wilson, I. A. (1992). Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257: 927-34.
105. McSparron, H., Blythe, M. J., Zygouri, C., Doytchinova, I. A. and Flower, D. R. (2003). JenPep: A novel computational information resource for immunobiology and vaccinology. J. Chem. Inf. Comput. Sci. 43: 1276-87.
106. Meyer, T. H., van Endert, P. M., Uebel, S., Ehring, B. and Tampé, R. (1994). Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Lett. 351: 443-7.
107. Mo, X. Y., Cascio, P., Lemerise, K., Goldberg, A. L. and Rock, K. (1999). Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides. J. Immunol. 163: 5851-9.
108. Monaco, J., Cho, S. and Attaya, M. (1990). Transport protein genes in the murine MHC - possible implications for antigen processing. Science 250: 1723-6.
109. Mormung, F., Neefjes, J. J. and Hämmerling, G. J. (1994). Peptide selection by MHC-encoded TAP transporters. Curr. Opin. Immunol. 6: 32-7.
110. Müller, K. M., Ebensperger, C. and Tampé, R. (1994). Nucleotide binding to the hydrophilic C-terminal domain of the transporter associated with antigen processing (TAP). J. Biol. Chem. 269: 14032-7.
111. Murray, C. W. and Verdonk, M. L. (2002). The consequences of translational and rotational entropy lost by small molecules on binding to proteins. J. Comp. Aided Mol. Dis. 16: 741-53.
112. Murugan, N. and Dai, Y. (2005). Prediction of MHC class II binding peptides based on an iterative learning model. Immunome Res. 1: 6.
113. Niedermann, G., King, G., Butz, S., Birsner, U., Grimm, R., Shabanowitz, J., Hunt, D. F. and Eichmann, K. (1996). The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides. Proc. Natl. Acad. Sci. USA 93: 8572-7.
114. Nielsen, M., Lundegaard, C., Worning, P., Hvid, C. S., Lamberth, K., Buus, S., Brunak, S. and Lund, O. (2004). Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics 20: 1388-97.
115. Nisato, D., Wadnon, J., Callet, G., Mettefeu, D., Assens, J. L., Plouzane, C., Tonnerre, B., Pliska, V., et al. (1987). Renin inhibitors. Free-Wilson and correlation analysis of the inhibitory potency of a series of pepstatin analogues on plasma renin. J. Med. Chem. 30: 2287-91.
116. Noguchi, H., Hanai, T., Honda, H., Harrison, L. C. and Kobayashi, T. (2001). Fuzzy neural network-based prediction of the motif for MHC class II binding peptides. J. Biosci. Bioeng. 92: 227-31.
117. Noguchi, H., Kato, R., Hanai, T., Matsubara, Y., Honda, H., Brusic, V. and Kobayashi, T. (2002). Hidden Markov model-based prediction of antigenic peptides that interact with MHC class II molecules. J. Biosci. Bioeng. 94: 264-70.
118. Orlowski, M. and Michaud, C. (1989). Pituitary multicatalytic proteinase complex. Specificity of components and aspects of proteolitic activity. Biochemistry 28: 9270-8.
119. Orlowski, M., Cardozo, C. and Michaud, C. (1993). Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry 16: 1563-72.
120. Parham, P., Lomen, C. E., Lawlor, D. A., Ways, J. P., Holmes, N., Coppin, H. L., Salter, R. D., Wan, A. M., et al. (1988). Proc. Natl. Acad. Sci. USA 85: 4005-9.
121. Park, K. S., Kim, H., Kim, N. G., Cho, S. Y., Choi, K. H., Seong, J. K. and Paik, Y. K. (2002). Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma. Hepatology 35: 1459-66.
122. Parker, K. C., Bednarek, M. A. and Coligan, J. E. (1994). Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152: 163-75.
123. Parker, K. C., Shields, M., DiBrino, M., Brooks, A. and Coligan, J. E. (1995). Peptide binding to MHC class I molecules: implications for antigenic peptide prediction. Immunol. Res. 14: 34-57.
124. Peters, B., Bulik, S., Tampé, R., van Endert, P. M. and Holzhütter, H. G. (2003). Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J. Immunol. 171: 1741-9.
125. Peters, B. and Sette, A. (2005). Generating quantitative models describing the sequence specificity of biological process with the stabilized matrix method. BMC Bioinformatics 6: 132.
126. Petricoin, E. F., Ornstein, D. K. and Liotta, L. A. (2004). Clinical proteomics: Applications for prostate cancer biomarker discovery and detection. Urol. Oncol. 22: 322-8.
127. Petrone, P. M. and Garcia, A.E. (2004). MHC-peptide binding is assisted by bound water molecules. J. Mol. Biol. 338: 419-35.
128. Raffa, R. B. (2001). Introduction: on the relevance of thermodynamics to pharmacology. In Drug - Receptor Thermodynamics: Introduction and Applications, (Raffa, R. B., ed.) Wiley pp. 3-12.
129. Rammensee, H. G., Friede, T. and Stevanoviic, S. (1995). MHC ligands and peptide motifs: first listing. Immunogenetics 41: 178-228.
130. Rao, J. and Whitesides, G. M. (1997). Tight binding of a dimeric derivative of vancomycin with dimeric L-Lys-D-Ala_D-Ala. J. Am. Chem. Soc. 119: 10286-90.
131. Rao, J., Lahiri, J., Isaacs, L., Weis, R. M. and Whitesides, G. M. (1998). Trivalent system from Vancomycin: D-Ala-D-Ala with higher affinity than Biotin: Avidin. Science 280: 708-11.
132. Riedesel, H., Kolbeck, B., Schmetzer, O. and Knapp, E. W. (2004). Peptide binding at class I major histocompatibility complex scored with linear functions and support vector machines. Genome Inform. 15: 198-212.
133. Rudensky, A. Y., Preston-Hulbert, P., Soon-Cheol, H., Barlow, A. and Janeway Jr., C. A. (1991). Sequence analysis of peptides bound to MHC class II molecules. Nature (London) 353: 622-7.
134. Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M. and Sette, A. (1993). Prominent role of secondary anchor residues in peptide binding to HLA-A*0201 molecules. Cell 74: 929-37.
135. Saper, M. A., Bjorkman, P. J. and Wiley, D.C. (1991). Refined structure of the human class histocompatibility antigen HLA-A2 at 2.6 Å. J. Mol. Biol. 219: 277-319.
136. Saric, T., Chang, S.-C., Hattori, A., York, I. A., Markant, S., Rock, K. L., Tsujimoto, M. and Goldberg, A. L. (2002). An IFN-γ-induced aminopeptidase in the ER, ERAPI, trims precursors to MHC class I-presented peptides. Nat. Immunol. 3: 1169-76.
137. Saxova, P., Buus, S., Brunak, S. and Ke??mir, C. (2003). Predicting proteosomal cleavage sites: a comparison of available methods. Int. Immunol. 15: 781-7.
138. Schaschke, N., Matschiner, G., Zettll, F., Marquardt, U., Bergner, A., Bode, W., Sommerhoff, C. P. and Moroder, L. (2001). Bivalent inhibition of human beta-tryptase. Chem. Biol. 8: 313-27.
139. Schirle, M., Weinschenk, T. and Stevanoví, S. (2001). Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens. J. Immunol. Methods 257: 1-16.
140. Schölkopf, B. and Smola, A. J. (2002). Learning with kernels: support vector machines, regularization, optimization, and beyond. Cambridge, Mass. MIT Press.
141. Schönbach, C., Koh, J. L., Sheng, X., Wong, L. and Brusic, V. (2000). FIMM, a database of functional molecular immunology. Nucleic Acids Res. 28: 222-4.
142. Schueler-Furman, O., Altuvia, Y., Sette, A. and Margalit, H. (2000). Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles. Protein Sci. 9: 1838-46.
143. Schumacher, T. N. M., Kantesaria, D. V., Heemels, M. T., Ashton-Rickardt, P. G., Shepherd, J. C., Früh, K., Yang, Y., Peterson, P. A., et al. (1994). Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J. Exp. Med. 179: 533-40.
144. Serwold, T. and Shastri, N. (1999). Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells. J. Immunol. 162: 4712-19.
145. Serwold, T., Gonzalez, F., Kim, J., Jacob, R. and Shastri, N. (2002). ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419: 480-3.
146. Sette, A. and Sidney, J. (1998). HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr. Opin. Immunol. 10: 478-82.
147. Sette, A., Livingstone, B., McKinney, D., Appella, E., Fikes, J., Sidney, J., Newman, M. and Chesnut, R. (2001). The development of multiepitope vaccines: epitope identification, vaccine design and clinical evaluation. Biologicals 29: 271-6.
148. Shuker, S. B., Hajduk, P. J., Meadows, R. P. and Fesik, S. W. (1996). Discovering high-affinity ligands for proteins: SAR by NMR. Science 274: 1531-4.
149. Sidney, J., Grey, H. M., Kubo, R. T. and Sette, A. (1996a). Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today 17: 261-6.
150. Sidney, J., Grey, H. M., Southwood, S., Celis, E., Wentworth, P. A., del Guercio, M. F., Kubo, R. T., Chesnut, R. W., et al. (1996b). Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide binding repertoires of common HLA molecules. Hum. Immunol. 45: 79-93.
151. Sidney, J., Southwood, S., Mann, D. L., Fernandez-Vina, M. A., Newman, M. J. and Sette, A. (2001). Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. Hum. Immunol. 62: 1200-16.
152. Smith, K. D. and Lutz, C. T. (1996). Peptide-dependent expression of HLAB7 on antigen processing-deficient T2 cells. J Immunol. 156: 3755-64.
153. Stoltze, L., Schirle, M., Schwarz, G., Schroeter, C., Thompson, M. W., Hersh, L. B., Kalbacher, H., Stevanovi??, S., et al. (2000). Two new proteases in the MHC class I processing pathway. Nat. Immunol. 1: 413-8.
154. Sudo, T., Kamikawaji, N., Kimura, A., Date, Y., Savoie, C. J., Nakashima, H., Furuichi, E., Kuhara, S., et al. (1995). Differences in MHC class I self peptide repertoires among HLA-A2 subtypes. J. Immunol. 155: 4749-56.
155. Tanaka, K. and Kasahara, M. (1998). The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-g-inducible proteasome activator PA28. Immunol. Rev. 163: 161-76.
156. Terada, Y. and Nanya, K. (2000). Free-Wilson analysis of the antibacterial activity of fluoronaphthyridines against various microbes. A new application of indicator variables. Pharmazie 55: 133-5.
157. Tmej, C., Chiba, P., Huber, M., Richter, E., Hitzler, M., Schaper, K. J. and Ecker, G. (1998). A combined Hansch/Free-Wilson approach as predictive tool in QSAR studies on propafenone-type modulators of multidrug resistance. Arch. Pharm. (Weinheim) 331: 233-40.
158. Todeschini, R. and Consonni, V. (2000). Handbook of molecular descriptors. Methods and Principles in Medicinal Chemistry (Mannhold, R., Kubinyi, H., Timmerman, H., eds.) vol.11 Wiley - VCH, Weinheim, 2000.
159. Toes, R. E., Nussbaum, A. K., Degermann, S., Schirle, M., Emmerich, N. P., Kraft, M., Laplace, C., Zwinderman, A., et al. (2001). Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 194: 1-12.
160. Tomic, S., Nilsson, L. and Wade, R. C. (2000). Nuclear receptor-DNA binding specificity: A COMBINE and Free-Wilson QSAR analysis. J. Med. Chem. 43: 1780-92.
161. Tong, J. C., Tan, T. W. and Ranganathan, S. (2004). Modeling the structure of bound peptide ligands to major histocompatibility complex. Protein Sci. 13: 2523-32.
162. Tong, J. C., Bramson, J., Kanduc, D., Chow, S., Sinha, A. A. and Ranganathan, S. (2006a). Modeling the bound conformation of Pemphigus Vulgaris-associated peptides to MHC Class II DR and DQ Alleles. Immunome Res. 2: 1.
163. Tong, J. C., Zhang, G. L., Tan, T. W., August, J. T., Brusic, V. and Ranganathan, S. (2006b). Prediction of HLA-DQ3.2beta ligands: evidence of multiple registers in class II binding peptides. Bioinformatics 22: 1232-8.
164. Toseland, C. P., Taylor, D. J., McSparron, H., Hemsley, S. L., Blythe, M. J., Paine, K., Doytchinova, I. A., Guan, P., et al. (2005). AntiJen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular data. Immunome Res. 1: 4.
165. van den Eynde, B. J. and Morel, S. (2001). Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. Curr. Opin. Immunol. 13: 147-53.
166. Vasmatzis, G., Zhang, C., Cornette, J. L. and DeLisi, C. (1996). Computational determination of side chain specificity for pockets in class I MHC molecules. Mol. Immunol. 33: 1231-9.
167. Vigneron, N., Stroobant, V., Chapiro, J., Ooms, A., Degiovanni, G., Morel, S., van der Bruggen, P., Boon, T., et al. (2004). An antigenic peptide produced by peptide splicing in the proteasome. Science 304: 587-90.
168. Vinitsky, A., Anton, L. C., Snyder, H. L., Orlowski, M., Bennink, J. R. and Yewdell, J. W. (1997). The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing. J. Immunol. 159: 554-64.
169. von Herrath, M. G., Coon, B., Lewicki, H., Mazarguil, H., Gairin, J. E. and Oldstone, M. B. (1998). In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. J. Immunol. 161: 5087-96.
170. Wan, S., Coveney, P. V. and Flower, D. R. (2005a). Molecular basis of peptide recognition by the TCR: affinity differences calculated using large scale computing. J. Immunol. 175: 1715-23.
171. Wan, S., Coveney, P. V. and Flower, D. R. (2005b). Peptide recognition by the T-cell receptor: comparison of binding free energies from thermodynamic integration, Poisson-Boltzmann and linear interaction energy approximations. Philos Transact. A Math. Phys. Eng. Sci. 363: 2037-53.
172. Wan, S., Coveney, P. and Flower, D.R. (2004). Large-scale molecular dynamics simulations of HLA-A*0201 complexed with a tumor-specific antigenic peptide: can the alpha3 and beta2m domains be neglected? J. Comput. Chem. 25: 1803-13.
173. Wold, S. (1995). PLS for Multivariate Linear Modeling. In Chemometric Methods in Molecular Design (van de Waterbeemd, H., ed.) VCH, Weinheim pp. 195-218.
174. Yang, Z. R. and Johnson, F. C. (2005). Prediction of T-cell epitopes using biosupport vector machines. J. Chem. Inf. Model. 45: 1424-8.
175. York, I. A., Chang, S.-C., Saric, T., Keys, J. A., Favreau, J. M., Goldberg, A. L. and Rock, K. L. (2002). The ER aminopeptidase ERAPI enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3: 1177-84.
176. Zacharias, M. and Springer, S. (2004). Conformational flexibility of the MHC class I alpha1-alpha2 domain in peptide bound and free states: a molecular dynamics simulation study. Biophys. J. 87: 2203-14.
177. Zhao, Y., Pinilla, C., Valmori, D., Martin, R. and Simon, R. (2003). Application of support vector machines for T-cell epitopes prediction. Bioinformatics 19: 1978-84.
178. Zhu, W., Wang, X., Ma, Y., Rao, M., Glimm, J. and Kovach, J. S. (2003). Detection of cancer-specific markers amid massive mass spectral data. Proc. Natl. Acad. Sci. USA 100: 14666-71.